科普赋能：让医疗科技触手可及 随着我国老年人口突破3 亿大关，老龄化带来的健康挑战与社会负担日益凸显。围绕人口老龄化加速背 景下的银龄健康需求，波士顿科学带来了多款与中国老龄患者需求紧密契合的微创介入解决方案，包括 用于房颤治疗的明星产品FARAWAVE NAV一次性使用磁定位心脏脉冲电场消融导管；房颤患者卒中预 防"利器"新一代WATCHMAN FLX Pro左心耳封堵器；用于心脏节律管理的S-ICD皮下植入式除颤器和 起搏器、除颤器；治疗良性前列腺增生的Rezūm前列腺热蒸汽治疗系列产品，以及神经调控领域改善帕 金森病症状的Vercise Genus植入式脑深部神经刺激（DBS）系列产品。 波士顿科学还带来多项突破性疗法，为患者带来更多元的治疗选择：可预防经导管主动脉瓣置换术 （TAVR）中发生脑卒中的SENTINEL抗栓塞脑保护装置 ；用于颈动脉狭窄创新术式经颈动脉血管重建 术（TCAR）的ENROUTE经颈动脉逆流血栓保护装置 ；用于原发性肝癌治疗的TheraSphere Y90钇 [90Y]玻璃微球系统；美国FDA唯一批准的肝动脉灌注（HAI）疗法产品Intera3000肝动脉灌注泵* ，为 结直肠 ...

0:00 进博"断货王"极速返场掀抢购潮 （潘洁拍摄、剪辑） 12月19日至21日，首届进博优品交易会在国家会展中心（上海）正式启幕。作为进博会会期之外的特定领域优质产品延展活动，此次交易会也是"共享 大市场·出口中国"系列活动的关键一环。 记者在现场看到，3H馆与4.1H馆内人头攒动，来自60多个国家的700多家企业携优质产品参展，直面消费者，让更多"进博同款"走入大众视野。 展台上，既有大洋洲直供的天然健康食品、欧洲匠心打造的精致家用设备，也有风靡美洲的潮流个护好物、尽显亚洲风情的特色美妆产品，款款皆是备 受追捧的"进博同款"新品。 这场主打消费体验的"小进博"，开展首日便吸引了众多进博会"老朋友"。其中，雅诗兰黛集团以集合店形式亮相，集结旗下12大品牌，倩碧、朗仕、汤 姆福特等品牌带来覆盖护肤、彩妆、香氛等品类的百余款新品，为消费者带来丰富的选购选择。 在"进博优品会"上，新西兰纽仕兰乳业展台没有采用传统的静态陈列，而是将展台全方位打造为一个沉浸式360度全景直播场域。 "进博会上的'断货王'，紧急空运惊喜放送，展台与直播间皆可轻松入手。"在"进博优品会"的现场，纽仕兰展台的主播正举着一罐牛初乳奶粉热情 ...

Core Insights - The 8th China International Import Expo (CIIE 2025) showcased over 2,800 enterprises from more than 100 countries, with a significant focus on medical technology innovations [2] - Three key trends emerged in the medical technology sector: higher global innovation density, stronger system collaboration, and deeper participation from domestic manufacturers [2] - Notable companies highlighted include Boston Scientific, Medtronic, Alcon, GE, Siemens, Intuitive Surgical, and Yuanhua Intelligent, covering a wide range of medical technologies [2] Group 1: Boston Scientific - Boston Scientific presented over 80 minimally invasive products, with six new products making their debut, including the FARAWAVE NAV catheter and AdVance XP sling [4][6] - Key innovations focus on integrated solutions for atrial fibrillation treatment, male stress urinary incontinence, and carotid artery reconstruction safety [6][7] - The company's diverse portfolio reflects a dual drive of global innovation and local manufacturing [7] Group 2: Medtronic - Medtronic showcased over 100 innovative technologies, emphasizing a systematic approach to future surgery and intelligent medical solutions [9][10] - The AiBLE™ digital innovation ecosystem was highlighted, integrating navigation, robotics, imaging, and monitoring for enhanced surgical precision [9] - Collaborations with local partners aim to enhance the adoption of smart spine surgery and laser ablation techniques [10] Group 3: Alcon - Alcon celebrated its 30th anniversary in China, presenting innovations across the entire eye health spectrum, including three new products [11][15] - Collaborations with local institutions aim to accelerate the implementation of innovative solutions in China [15] - The company announced plans for local production of its Wavelight® excimer laser surgery equipment, enhancing the domestic supply chain [15] Group 4: Intuitive Surgical - Intuitive Surgical, a consistent participant, showcased its surgical robots and digital innovations, emphasizing a patient-first approach [19] - The Da Vinci surgical system has served over 810,000 patients in China, with new systems entering the regulatory approval process [19] - The company is building a comprehensive ecosystem that integrates diagnosis, treatment, and training [20] Group 5: GE Healthcare - GE Healthcare introduced nearly 40 innovative products, including 18 new launches and 9 global debuts, focusing on advanced imaging technologies [29][31] - The Expert X quantum CT system and MR-PET technology were highlighted for their capabilities in cardiac imaging and metabolic assessment [31] Group 6: Siemens Healthineers - Siemens Healthineers emphasized its commitment to precision diagnosis and treatment for major diseases, showcasing the ARTIS icono ceiling Xpand system [35][37] - Innovations in CT and AI cardiovascular ultrasound technologies aim to enhance diagnostic efficiency and safety [37] Group 7: Abbott - Abbott presented over ten innovative products, including the AVEIR™ DR dual-chamber leadless pacemaker, addressing chronic disease management [21][24] - The company’s offerings span multiple health management areas, including cardiovascular and diabetes care [27] Group 8: Yuanhua Intelligent - Yuanhua Intelligent introduced the world's first "five-in-one" orthopedic surgical robot system, enhancing the digital workflow in orthopedic surgeries [25][28] - The system integrates various surgical procedures, marking a significant advancement in the field [28] Group 9: Other Notable Companies - Companies like Edwards Lifesciences, Johnson & Johnson, and others showcased innovative solutions in heart valve repair, minimally invasive surgery, and advanced imaging technologies [42][45][46] - The overall trend indicates a shift towards integrated systems and collaborative innovations across the medical technology landscape [66][67]

Core Viewpoint - The article emphasizes the importance of innovative medical technologies showcased at the China International Import Expo, particularly those that can effectively transition from exhibition to clinical application, highlighting Boston Scientific's commitment to "innovation for life" through its latest minimally invasive products [2][29]. Group 1: Cardiac Health Innovations - Boston Scientific introduced the FARAWAVE NAV catheter, a key component of the FARAPULSE PFA system, which utilizes non-thermal energy for precise cardiac ablation, minimizing damage to surrounding tissues [5][7]. - The FARAWAVE NAV features magnetic navigation and real-time modeling capabilities, enhancing procedural consistency and safety for both novice and experienced practitioners [7][10]. - The integration of the FARAPULSE PFA system with the WATCHMAN FLX Pro device represents a comprehensive approach to atrial fibrillation management, addressing both rhythm control and stroke prevention in a single treatment pathway [8][10]. Group 2: Urological Health Innovations - The AdVance XP system, designed specifically for male stress urinary incontinence, employs an anatomical repositioning technique to restore urinary control, marking a significant advancement in minimally invasive urological treatments [11][14]. - This system's design optimizes structure and materials for improved surgical control and patient outcomes, allowing for real-time adjustments during procedures [13][14]. - The clinical significance of AdVance XP extends beyond physical recovery, aiming to enhance patients' quality of life by addressing both physiological and psychological aspects of urinary incontinence [14][15]. Group 3: Peripheral Vascular Health Innovations - The ENROUTE device introduces a novel "reverse flow protection" mechanism for carotid artery reconstruction, providing real-time protection against embolic events during surgery [16][19]. - This approach is particularly beneficial for high-risk patients who may not tolerate traditional surgical methods, offering a safer alternative for carotid artery disease management [19][20]. - The shift in focus from merely achieving vascular access to ensuring procedural safety reflects a broader trend in minimally invasive techniques, emphasizing the importance of protective innovations in surgical practices [20][21]. Group 4: Diverse Clinical Applications - Boston Scientific also showcased three additional products targeting metabolic, circulatory, and oncological treatments, demonstrating its commitment to addressing a wide range of clinical needs [22][28]. - The Orbera 365 system offers a reversible weight loss solution through endoscopic gastric balloon placement, aligning with national health initiatives for weight management [22]. - TIVUS and Intera 3000 represent advancements in hypertension and cancer treatment, respectively, highlighting the company's strategy to innovate across multiple disease areas [24][26]. Group 5: Digital Solutions and Future Directions - The integration of AI technologies in Boston Scientific's offerings aims to enhance clinical decision-making through data-driven insights, reinforcing the company's "smart minimally invasive" strategy [29][30]. - The successful transition of 22 showcased products from exhibition to market underscores the importance of innovation in improving patient outcomes and accessibility to advanced medical technologies [29][30]. - The overarching goal of these innovations is to ensure that new technologies are not only functional but also closely aligned with the real needs of healthcare providers and patients [30].